Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kakeya

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cancer Research|March 4, 1998
Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibioticH Kakeya, R Onose, P C Liu, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Genetic analysis of azole resistance in the Darlington strain of Candida albicansH Kakeya, Y Miyazaki, H Miyazaki, et al.
The Journal of Hospital Infection|February 22, 2023
Predictors of hypervirulent Klebsiella pneumoniae infections: a systematic review and meta-analysisH Namikawa, K-I Oinuma, K Yamada, et al.
The Journal of Hospital Infection|October 6, 2023
Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysisH Namikawa, W Imoto, K Yamada, et al.
The Journal of Antibiotics|September 1, 1993
Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation, and characterizationM Imoto, H Kakeya, T Sawa, et al.
The Journal of Antibiotics|April 1, 1997
Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cellsH Kakeya, H P Zhang, K Kobinata, et al.
Clinical and Experimental Dermatology|November 13, 2010
Rhizomucor variabilis infection in human cutaneous mucormycosisH Tomita, E Muroi, M Takenaka, et al.
Journal of Natural Products|July 1, 1997
RKS-1778, a new mammalian cell-cycle inhibitor and a key intermediate of the [11]cytochalasin groupH Kakeya, M Morishita, C Onozawa, et al.
The Journal of Antibiotics|February 1, 1996
Acetophthalidin, a novel inhibitor of mammalian cell cycle, produced by a fungus isolated from a sea sedimentC B Cui, M Ubukata, H Kakeya, et al.
The Journal of Antibiotics|January 5, 2002
Lucilactaene, a new cell cycle inhibitor in p53-transfected cancer cells, produced by a Fusarium spH Kakeya, S Kageyama, L Nie, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Research|March 4, 1998
Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibioticH Kakeya, R Onose, P C Liu, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Genetic analysis of azole resistance in the Darlington strain of Candida albicansH Kakeya, Y Miyazaki, H Miyazaki, et al.
The Journal of Hospital Infection|February 22, 2023
Predictors of hypervirulent Klebsiella pneumoniae infections: a systematic review and meta-analysisH Namikawa, K-I Oinuma, K Yamada, et al.
The Journal of Hospital Infection|October 6, 2023
Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysisH Namikawa, W Imoto, K Yamada, et al.
The Journal of Antibiotics|September 1, 1993
Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation, and characterizationM Imoto, H Kakeya, T Sawa, et al.
The Journal of Antibiotics|April 1, 1997
Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cellsH Kakeya, H P Zhang, K Kobinata, et al.
Clinical and Experimental Dermatology|November 13, 2010
Rhizomucor variabilis infection in human cutaneous mucormycosisH Tomita, E Muroi, M Takenaka, et al.
Journal of Natural Products|July 1, 1997
RKS-1778, a new mammalian cell-cycle inhibitor and a key intermediate of the [11]cytochalasin groupH Kakeya, M Morishita, C Onozawa, et al.
The Journal of Antibiotics|February 1, 1996
Acetophthalidin, a novel inhibitor of mammalian cell cycle, produced by a fungus isolated from a sea sedimentC B Cui, M Ubukata, H Kakeya, et al.
The Journal of Antibiotics|January 5, 2002
Lucilactaene, a new cell cycle inhibitor in p53-transfected cancer cells, produced by a Fusarium spH Kakeya, S Kageyama, L Nie, et al.
Pageof 6